I am pleased to announce that Dr Owen Bowden-Jones has been reappointed to the ACMD both as a member and as its Chair. This re-appointment is for a three-year term, beginning on 1 January 2020. Dr Bowden-Jones is an experienced clinician who provides assessment and treatment for people experiencing harms from emerging problem drugs.
The ACMD was established under the Misuse of Drugs Act 1971 and provides advice to Government on issues related to the harms of drugs. It also has a statutory role under the Psychoactive Substances Act 2016.